No growth in revenue compared to H2 2021. Soaring expenses. Continued failure to execute on new products. Existing product runway facing imminent patent expiry. Incredibly overvalued.
Ann: 2022 Half Year Financial Results, page-3
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.65 |
Change
0.030(0.83%) |
Mkt cap ! $1.101B | |||
| Open | High | Low | Value | Volume |
| $3.66 | $3.66 | $3.62 | $87.67K | 24.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 4945 | $3.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.66 | 4602 | 15 |
View Market Depth
| Last trade - 12.02pm 09/10/2024 (20 minute delay) ? |
| NAN (ASX) Chart |